Manel Sabaté

发表

Initial Experience of Patient Selection for Mitraclip-XTR in a Single Center

Laura Sanchis, Xavier Freixa, Marta Sitges, 2019 .

Inhibidors de l’adenosina difosfat en pacients amb síndrome coronària aguda sense elevació del segment ST

Josepa Mauri, Manel Sabaté, Antoni Carol, 2015 .

Introducción: Iniciativa Stent for Life en España o la necesidad imperiosa de pasar de la evidencia a la asistencia integrada y transversal

Manel Sabaté, M. Sabaté, 2011 .

This appendix has been provided by the authors to give readers additional information about their work.

Roberto Garbo, Carlo Briguori, Peter Jüni, 2015 .

Percutaneous transcatheter aortic valve implantation: present and future perspective

Xavier Freixa, Manel Sabaté, Diego Fernández, 2013, Expert review of medical devices.

Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.

Fernando Alfonso, Manel Sabaté, Raúl Moreno, 2005, Journal of the American College of Cardiology.

The risk of over-regulation

Manel Sabaté, M. Degertekin, M. Sabaté, 2011 .

Assessment of plaque composition by intravascular ultrasound and near-infrared spectroscopy: from PROSPECT I to PROSPECT II.

Manel Sabaté, Salvatore Brugaletta, S. Brugaletta, 2014, Circulation journal : official journal of the Japanese Circulation Society.

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

Marco Valgimigli, Manel Sabaté, Adnan Kastrati, 2007, The New England journal of medicine.

Bioresorbable vascular scaffolds technology: current use and future developments

Manel Sabaté, Salvatore Brugaletta, S. Brugaletta, 2016, Medical devices.

Bioresorbable vascular scaffold implantation in acute coronary syndromes: clinical evidence, tips and tricks

Manel Sabaté, Salvatore Brugaletta, S. Brugaletta, 2015, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Factors Determining Success in Percutaneous Revascularization of Chronic Total Coronary Occlusion, Multidetector Computed Tomography Analysis

Francesc Carreras, Rubén Leta, Manel Sabaté, 2012 .

One‐year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent

Patrick W Serruys, Manel Sabaté, Stephan Windecker, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

Simon Wandel, Peter Jüni, Manel Sabaté, 2007, The Lancet.

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

Bernard Chevalier, Jan J Piek, Patrick W Serruys, 2016, The Lancet.

Corrigendum to: ‘2013 ESC guidelines on the management of stable coronary artery disease’

Nikolaus Marx, Roxy Senior, Manel Sabaté, 2014 .

Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial.

Bernard Chevalier, Jan J Piek, Patrick W Serruys, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studies.

Fernando Alfonso, Manel Sabaté, Raúl Moreno, 2004, Journal of the American College of Cardiology.